Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Bitetto

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrenceEdmondo Falleti, Carlo Fabris, Sara Cmet, et al.
Cytokine|November 30, 2011
Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis CEdmondo Falleti, Sara Cmet, Carlo Fabris, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 7, 2012
Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patientsEdmondo Falleti, Davide Bitetto, Carlo Fabris, et al.
Journal of Medical Virology|March 21, 2012
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminasesCarlo Fabris, Edmondo Falleti, Annarosa Cussigh, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis CDavide Bitetto, Giovanna Fattovich, Carlo Fabris, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapyDavide Bitetto, Nadia Bortolotti, Edmondo Falleti, et al.
Oncology|November 27, 2009
Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver diseaseEdmondo Falleti, Carlo Fabris, Pierluigi Toniutto, et al.
Clinical Transplantation|February 13, 2009
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progressionPierluigi Toniutto, Rosalba Minisini, Carlo Fabris, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 6, 2022
Immunogenicity and safety of a third dose of anti-SARS-CoV-2 BNT16b2 vaccine in liver transplant recipientsPierluigi Toniutto, Annarosa Cussigh, Sara Cmet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 24, 2010
Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis CDavide Bitetto, Carlo Fabris, Ezio Fornasiere, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrenceEdmondo Falleti, Carlo Fabris, Sara Cmet, et al.
Cytokine|November 30, 2011
Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis CEdmondo Falleti, Sara Cmet, Carlo Fabris, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 7, 2012
Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patientsEdmondo Falleti, Davide Bitetto, Carlo Fabris, et al.
Journal of Medical Virology|March 21, 2012
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminasesCarlo Fabris, Edmondo Falleti, Annarosa Cussigh, et al.
Hepatology (Baltimore, Md.)|April 12, 2011
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis CDavide Bitetto, Giovanna Fattovich, Carlo Fabris, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapyDavide Bitetto, Nadia Bortolotti, Edmondo Falleti, et al.
Oncology|November 27, 2009
Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver diseaseEdmondo Falleti, Carlo Fabris, Pierluigi Toniutto, et al.
Clinical Transplantation|February 13, 2009
Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progressionPierluigi Toniutto, Rosalba Minisini, Carlo Fabris, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 6, 2022
Immunogenicity and safety of a third dose of anti-SARS-CoV-2 BNT16b2 vaccine in liver transplant recipientsPierluigi Toniutto, Annarosa Cussigh, Sara Cmet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 24, 2010
Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis CDavide Bitetto, Carlo Fabris, Ezio Fornasiere, et al.
Pageof 7